(VRSN) VeriSign - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US92343E1029
Registry, DNS, Root, Certificates, Security
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 1.10% |
| Yield CAGR 5y | % |
| Payout Consistency | 6.1% |
| Payout Ratio | 26.9% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 21.5% |
| Value at Risk 5%th | 33.0% |
| Relative Tail Risk | -6.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.76 |
| Alpha | 13.27 |
| CAGR/Max DD | 0.26 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.590 |
| Beta | 0.415 |
| Beta Downside | 0.372 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.35% |
| Mean DD | 10.74% |
| Median DD | 10.38% |
Description: VRSN VeriSign October 14, 2025
VeriSign, Inc. (NASDAQ: VRSN) operates the core infrastructure that powers the public internet, maintaining two of the thirteen root DNS servers and acting as the exclusive registry for the .com and .net top-level domains, which together account for roughly 46 % of all globally registered domain names.
Beyond .com/.net, the company runs the .name and .cc registries and provides back-end DNS services for .edu and other delegated zones, ensuring authoritative resolution, security, and high-availability for billions of end-user queries.
Financially, VeriSign reported FY 2024 revenue of $1.84 billion with an operating margin of 71 %, reflecting the high-margin, subscription-based nature of its domain-registry and DNS-security offerings; the firm’s free cash flow consistently exceeds $800 million annually, supporting a dividend yield near 4 %.
Key growth drivers include rising corporate spending on cyber-security and DNS-based threat mitigation, the continued expansion of e-commerce (which fuels demand for reliable .com/.net domains), and the broader shift toward cloud-native networking that elevates the value of resilient DNS infrastructure.
For a deeper, data-driven assessment of VeriSign’s valuation dynamics, you may find it worthwhile to explore the analytics platform ValueRay, which aggregates sector-wide benchmarks and forward-looking metrics.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (811.0m TTM) > 0 and > 6% of Revenue (6% = 97.6m TTM) |
| FCFTA 0.72 (>2.0%) and ΔFCFTA 13.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -38.03% (prev -52.44%; Δ 14.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.74 (>3.0%) and CFO 1.03b > Net Income 811.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.55b) to EBITDA (1.16b) ratio: 1.34 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (93.6m) change vs 12m ago -3.80% (target <= -2.0% for YES) |
| Gross Margin 87.97% (prev 87.58%; Δ 0.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 113.5% (prev 105.5%; Δ 8.03pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.60 (EBITDA TTM 1.16b / Interest Expense TTM 76.9m) >= 6 (WARN >= 3) |
Altman Z'' -26.08
| (A) -0.44 = (Total Current Assets 688.4m - Total Current Liabilities 1.31b) / Total Assets 1.40b |
| (B) -8.54 = Retained Earnings (Balance) -11.98b / Total Assets 1.40b |
| warn (B) unusual magnitude: -8.54 — check mapping/units |
| (C) 0.78 = EBIT TTM 1.12b / Avg Total Assets 1.43b |
| (D) -0.59 = Book Value of Equity -2.05b / Total Liabilities 3.45b |
| Total Rating: -26.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.54
| 1. Piotroski 7.50pt |
| 2. FCF Yield 4.08% |
| 3. FCF Margin 61.79% |
| 4. Debt/Equity -0.87 |
| 5. Debt/Ebitda 1.34 |
| 7. RoE -40.66% |
| 8. Rev. Trend 99.07% |
| 9. EPS Trend 96.71% |
What is the price of VRSN shares?
As of December 14, 2025, the stock is trading at USD 242.00 with a total of 679,269 shares traded.
Over the past week, the price has changed by -3.02%, over one month by -3.09%, over three months by -14.98% and over the past year by +22.61%.
Over the past week, the price has changed by -3.02%, over one month by -3.09%, over three months by -14.98% and over the past year by +22.61%.
Is VRSN a buy, sell or hold?
VeriSign has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold VRSN.
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the VRSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 295.5 | 22.1% |
| Analysts Target Price | 295.5 | 22.1% |
| ValueRay Target Price | 250.1 | 3.3% |
VRSN Fundamental Data Overview December 03, 2025
Market Cap USD = 23.45b (23.45b USD * 1.0 USD.USD)
P/E Trailing = 29.2564
P/E Forward = 25.8398
P/S = 14.4141
P/EG = 2.8653
Beta = 0.783
Revenue TTM = 1.63b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.16b USD
Long Term Debt = 1.79b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 24.62b USD (23.45b + Debt 1.79b - CCE 617.7m)
Interest Coverage Ratio = 14.60 (Ebit TTM 1.12b / Interest Expense TTM 76.9m)
FCF Yield = 4.08% (FCF TTM 1.01b / Enterprise Value 24.62b)
FCF Margin = 61.79% (FCF TTM 1.01b / Revenue TTM 1.63b)
Net Margin = 49.86% (Net Income TTM 811.0m / Revenue TTM 1.63b)
Gross Margin = 87.97% ((Revenue TTM 1.63b - Cost of Revenue TTM 195.7m) / Revenue TTM)
Gross Margin QoQ = 88.36% (prev 88.02%)
Tobins Q-Ratio = 17.54 (Enterprise Value 24.62b / Total Assets 1.40b)
Interest Expense / Debt = 1.06% (Interest Expense 18.9m / Debt 1.79b)
Taxrate = 21.68% (58.9m / 271.7m)
NOPAT = 879.1m (EBIT 1.12b * (1 - 21.68%))
Current Ratio = 0.53 (Total Current Assets 688.4m / Total Current Liabilities 1.31b)
Debt / Equity = -0.87 (negative equity) (Debt 1.79b / totalStockholderEquity, last quarter -2.05b)
Debt / EBITDA = 1.34 (Net Debt 1.55b / EBITDA 1.16b)
Debt / FCF = 1.54 (Net Debt 1.55b / FCF TTM 1.01b)
Total Stockholder Equity = -1.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 57.78% (Net Income 811.0m / Total Assets 1.40b)
RoE = -40.66% (negative equity) (Net Income TTM 811.0m / Total Stockholder Equity -1.99b)
RoCE = -541.7% (out of range, set to none) (EBIT 1.12b / Capital Employed (Equity -1.99b + L.T.Debt 1.79b))
RoIC = -425.7% (out of range, set to none) (NOPAT 879.1m / Invested Capital -206.5m)
WACC = 7.07% (E(23.45b)/V(25.24b) * Re(7.55%) + D(1.79b)/V(25.24b) * Rd(1.06%) * (1-Tc(0.22)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.21%
[DCF Debug] Terminal Value 79.20% ; FCFE base≈943.8m ; Y1≈1.01b ; Y5≈1.21b
Fair Price DCF = 229.1 (DCF Value 21.24b / Shares Outstanding 92.7m; 5y FCF grow 7.40% → 3.0% )
EPS Correlation: 96.71 | EPS CAGR: 12.08% | SUE: 0.89 | # QB: 2
Revenue Correlation: 99.07 | Revenue CAGR: 5.71% | SUE: 1.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.28 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=9.67 | Chg30d=+0.110 | Revisions Net=+0 | Growth EPS=+9.0% | Growth Revenue=+4.8%
P/E Trailing = 29.2564
P/E Forward = 25.8398
P/S = 14.4141
P/EG = 2.8653
Beta = 0.783
Revenue TTM = 1.63b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.16b USD
Long Term Debt = 1.79b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 24.62b USD (23.45b + Debt 1.79b - CCE 617.7m)
Interest Coverage Ratio = 14.60 (Ebit TTM 1.12b / Interest Expense TTM 76.9m)
FCF Yield = 4.08% (FCF TTM 1.01b / Enterprise Value 24.62b)
FCF Margin = 61.79% (FCF TTM 1.01b / Revenue TTM 1.63b)
Net Margin = 49.86% (Net Income TTM 811.0m / Revenue TTM 1.63b)
Gross Margin = 87.97% ((Revenue TTM 1.63b - Cost of Revenue TTM 195.7m) / Revenue TTM)
Gross Margin QoQ = 88.36% (prev 88.02%)
Tobins Q-Ratio = 17.54 (Enterprise Value 24.62b / Total Assets 1.40b)
Interest Expense / Debt = 1.06% (Interest Expense 18.9m / Debt 1.79b)
Taxrate = 21.68% (58.9m / 271.7m)
NOPAT = 879.1m (EBIT 1.12b * (1 - 21.68%))
Current Ratio = 0.53 (Total Current Assets 688.4m / Total Current Liabilities 1.31b)
Debt / Equity = -0.87 (negative equity) (Debt 1.79b / totalStockholderEquity, last quarter -2.05b)
Debt / EBITDA = 1.34 (Net Debt 1.55b / EBITDA 1.16b)
Debt / FCF = 1.54 (Net Debt 1.55b / FCF TTM 1.01b)
Total Stockholder Equity = -1.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 57.78% (Net Income 811.0m / Total Assets 1.40b)
RoE = -40.66% (negative equity) (Net Income TTM 811.0m / Total Stockholder Equity -1.99b)
RoCE = -541.7% (out of range, set to none) (EBIT 1.12b / Capital Employed (Equity -1.99b + L.T.Debt 1.79b))
RoIC = -425.7% (out of range, set to none) (NOPAT 879.1m / Invested Capital -206.5m)
WACC = 7.07% (E(23.45b)/V(25.24b) * Re(7.55%) + D(1.79b)/V(25.24b) * Rd(1.06%) * (1-Tc(0.22)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -4.21%
[DCF Debug] Terminal Value 79.20% ; FCFE base≈943.8m ; Y1≈1.01b ; Y5≈1.21b
Fair Price DCF = 229.1 (DCF Value 21.24b / Shares Outstanding 92.7m; 5y FCF grow 7.40% → 3.0% )
EPS Correlation: 96.71 | EPS CAGR: 12.08% | SUE: 0.89 | # QB: 2
Revenue Correlation: 99.07 | Revenue CAGR: 5.71% | SUE: 1.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.28 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=9.67 | Chg30d=+0.110 | Revisions Net=+0 | Growth EPS=+9.0% | Growth Revenue=+4.8%
Additional Sources for VRSN Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle